Skip to content
10-Q

Quarterly Report

Bolt Biotherapeutics, Inc. BOLT

0001193125-25-277549

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 5, 2025 1.92M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.92M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.92M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 1.91M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 1.91M sh
Capex Q3 2025 · Sep 30, 2025 $72K
Capex Q3 2025 · Sep 30, 2024 $41K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$32.69M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$46.86M
Short Term Investments Q3 2025 · Sep 30, 2025 $14.16M
Short Term Investments Q3 2025 · Dec 31, 2024 $40.12M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $17.75M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $7.21M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $9.37M
Stockholders Equity Q3 2025 · Sep 30, 2025 $32.1M
Stockholders Equity Q3 2025 · Jun 30, 2025 $38.84M
Stockholders Equity Q3 2025 · Dec 31, 2024 $57.2M
Stockholders Equity Q3 2025 · Sep 30, 2024 $72.03M
Stockholders Equity Q3 2025 · Jun 30, 2024 $85.86M
Stockholders Equity Q3 2025 · Dec 31, 2023 $112.74M
Current Liabilities Q3 2025 · Sep 30, 2025 $9.97M
Current Liabilities Q3 2025 · Dec 31, 2024 $15.86M
Total Liabilities Q3 2025 · Sep 30, 2025 $32.95M
Total Liabilities Q3 2025 · Dec 31, 2024 $42.43M
Current Assets Q3 2025 · Sep 30, 2025 $35.61M
Current Assets Q3 2025 · Dec 31, 2024 $50.81M
Total Assets Q3 2025 · Sep 30, 2025 $65.05M
Total Assets Q3 2025 · Dec 31, 2024 $99.63M
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.72
Eps Diluted Q3 2025 · Sep 30, 2025 −$13.94
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$7.93
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$24.73
Eps Basic Q3 2025 · Sep 30, 2025 −$3.72
Eps Basic Q3 2025 · Sep 30, 2025 −$13.94
Eps Basic restated Q3 2025 · Sep 30, 2024 −$7.93
Eps Basic restated Q3 2025 · Sep 30, 2024 −$24.73
Sga Expense Q3 2025 · Sep 30, 2025 $3.34M
Sga Expense Q3 2025 · Sep 30, 2025 $10.68M
Sga Expense Q3 2025 · Sep 30, 2024 $3.8M
Sga Expense Q3 2025 · Sep 30, 2024 $14.51M
Rd Expense Q3 2025 · Sep 30, 2025 $6.54M
Rd Expense Q3 2025 · Sep 30, 2025 $23.55M
Rd Expense Q3 2025 · Sep 30, 2024 $13.79M
Rd Expense Q3 2025 · Sep 30, 2024 $45.75M
Net Income Q3 2025 · Sep 30, 2025 −$7.14M
Net Income Q3 2025 · Sep 30, 2025 −$26.75M
Net Income Q3 2025 · Sep 30, 2024 −$15.18M
Net Income Q3 2025 · Sep 30, 2024 −$47.18M
Operating Income Q3 2025 · Sep 30, 2025 −$7.7M
Operating Income Q3 2025 · Sep 30, 2025 −$29.03M
Operating Income Q3 2025 · Sep 30, 2024 −$16.44M
Operating Income Q3 2025 · Sep 30, 2024 −$56.13M
Revenue Q3 2025 · Sep 30, 2025 $2.17M
Revenue Q3 2025 · Sep 30, 2025 $5.2M
Revenue Q3 2025 · Sep 30, 2024 $1.14M
Revenue Q3 2025 · Sep 30, 2024 $7.69M